Genomic and transcriptome analysis revealing an oncogenic functional module in meningiomas

Neurosurgical Focus

Volumn 35, Issue 6, 2013, Pages

  Chang, Xiao ^a   Shi, Lingling ^b   Gao, Fan ^a   Russin, Jonathan ^a   Zeng, Liyun ^a   He, Shuhan ^a   Chen, Thomas C ^a   Giannotta, Steven L ^a   Weisenberger, Daniel J ^a   Zada, Gabriel ^a   Wang, Kai ^a   Mack, William J ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b JINAN UNIVERSITY   (China)

Author keywords

Copy number alteration; Hub genes; Meningioma; WGCNA

Indexed keywords

ARTICLE; CARCINOGENESIS; CHROMOSOME 22; GENE DOSAGE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETICS; GENOMICS; HUMAN; MENINGIOMA; METABOLISM;

CARCINOGENESIS; CHROMOSOMES, HUMAN, PAIR 22; GENE DOSAGE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; GENOMICS; HUMANS; MENINGEAL NEOPLASMS; MENINGIOMA;

EID: 84890250461     PISSN: None     EISSN: 10920684     Source Type: Journal    
DOI: 10.3171/2013.10.FOCUS13326     Document Type: Article

References (58)

1. Bader GD, Hogue CW: An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics 4:2, 2003
2. Barabási AL, Oltvai ZN: Network biology: understanding the cell's functional organization. Nat Rev Genet 5:101-113, 2004
3. Batistatou A, Charalabopoulos AK, Scopa CD, Nakanishi Y, Kappas A, Hirohashi S, et al: Expression patterns of dysadherin and E-cadherin in lymph node metastases of colorectal carcinoma. Virchows Arch 448:763-767, 2006
4. Beroukhim R, Getz G, Nghiemphu L, Barretina J, Hsueh T, Linhart D, et al: Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc Natl Acad Sci U S A 104:20007-20012, 2007
5. Chang X, Liu S, Yu YT, Li YX, Li YY: Identifying modules of coexpressed transcript units and their organization of Saccharopolyspora erythraea from time series gene expression profiles. PLoS ONE 5:e12126, 2010
6. Chang X, Wang Z, Hao P, Li YY, Li YX: Exploring mitochondrial evolution and metabolism organization principles by comparative analysis of metabolic networks. Genomics 95: 339-344, 2010
7. Diskin SJ, Li M, Hou C, Yang S, Glessner J, Hakonarson H, et al: Adjustment of genomic waves in signal intensities from whole-genome SNP genotyping platforms. Nucleic Acids Res 36:e126, 2008
8. Dobbins SE, Broderick P, Melin B, Feychting M, Johansen C, Andersson U, et al: Common variation at 10p12.31 near MLLT10 influences meningioma risk. Nat Genet 43:825-827, 2011
9. Emilsson V, Thorleifsson G, Zhang B, Leonardson AS, Zink F, Zhu J, et al: Genetics of gene expression and its effect on disease. Nature 452:423-428, 2008
10. Fèvre-Montange M, Champier J, Durand A, Wierinckx A, Honnorat J, Guyotat J, et al: Microarray gene expression profiling in meningiomas: differential expression according to grade or histopathological subtype. Int J Oncol 35:1395-1407, 2009
11. Gao F, Shi L, Russin J, Zeng L, Chang X, He S, et al: DNA methylation in the malignant transformation of meningiomas. PLoS ONE 8:e54114, 2013
12. Giusti M, Bocca L, Florio T, Corsaro A, Spaziante R, Schettini G, et al: In vitro effect of human recombinant leptin and expression of leptin receptors on growth hormone-secreting human pituitary adenomas. Clin Endocrinol (Oxf) 57:449-455, 2002
13. Han JD, Bertin N, Hao T, Goldberg DS, Berriz GF, Zhang LV, et al: Evidence for dynamically organized modularity in the yeast protein-protein interaction network. Nature 430:88-93, 2004
14. Horvath S, Zhang B, Carlson M, Lu KV, Zhu S, Felciano RM, et al: Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc Natl Acad Sci U S A 103:17402-17407, 2006
15. Huang W, Sherman BT, Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57, 2009
16. Ivliev AE, 't Hoen PA, Sergeeva MG: Coexpression network analysis identifies transcriptional modules related to proastrocytic differentiation and sprouty signaling in glioma. Cancer Res 70:10060-10070, 2010
17. Jayapandian M, Chapman A, Tarcea VG, Yu C, Elkiss A, Ianni A, et al: Michigan Molecular Interactions (MiMI): putting the jigsaw puzzle together. Nucleic Acids Res 35 (Database issue):D566-D571, 2007
18. Keller A, Ludwig N, Backes C, Romeike BF, Comtesse N, Henn W, et al: Genome wide expression profiling identifies specific deregulated pathways in meningioma. Int J Cancer 124:346-351, 2009
19. Kraft R, Krause P, Jung S, Basrai D, Liebmann L, Bolz J, et al: BK channel openers inhibit migration of human glioma cells. Pflugers Arch 446:248-255, 2003
20. Kristiansen MT, Clausen LR, Nielsen S, Blaabjerg O, Ledet T, Rasmussen LM, et al: Expression of leptin receptor isoforms and effects of leptin on the proliferation and hormonal secretion in human pituitary adenomas. Horm Res 62:129-136, 2004
21. Langfelder P, Horvath S: WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9:559, 2008
22. Lee JY, Finkelstein S, Hamilton RL, Rekha R, King JT Jr, Omalu B: Loss of heterozygosity analysis of benign, atypical, and anaplastic meningiomas. Neurosurgery 55:1163-1173, 2004
23. Lee Y, Liu J, Patel S, Cloughesy T, Lai A, Farooqi H, et al: Genomic landscape of meningiomas. Brain Pathol 20:751-762, 2010
24. Lekanne Deprez RH, Riegman PH, Groen NA, Warringa UL, van Biezen NA, Molijn AC, et al: Cloning and characterization of MN1, a gene from chromosome 22q11, which is disrupted by a balanced translocation in a meningioma. Oncogene 10:1521-1528, 1995
25. Lister J, Forrester WC, Baron MH: Inhibition of an erythroid differentiation switch by the helix-loop-helix protein Id1. J Biol Chem 270:17939-17946, 1995
26. Liu T, Jankovic D, Brault L, Ehret S, Baty F, Stavropoulou V, et al: Functional characterization of high levels of meningioma 1 as collaborating oncogene in acute leukemia. Leukemia 24:601-612, 2010
27. Liu X, Chang Y, Reinhart PH, Sontheimer H, Chang Y: Cloning and characterization of glioma BK, a novel BK channel isoform highly expressed in human glioma cells. J Neurosci 22:1840-1849, 2002
28. Louis DN, Scheithauer BW, Budka H, von Deimling A, Kepes JJ: Meningiomas, in Kleihues P, Cavenee WK (eds): World Health Organization Classification of Tumours. Pathology and Genetics: Tumours of the Nervous System. Lyon: IARC Press, 2000, pp 176-189
29. Mar JC, Wells CA, Quackenbush J: Defining an informativeness metric for clustering gene expression data. Bioinformatics 27:1094-1100, 2011
30. Meester-Smoor MA, Janssen MJ, Grosveld GC, de Klein A, van IJcken WF, Douben H, et al: MN1 affects expression of genes involved in hematopoiesis and can enhance as well as inhibit RAR/RXR-induced gene expression. Carcinogenesis 29:2025-2034, 2008
31. Meester-Smoor MA, Molijn AC, Zhao Y, Groen NA, Groffen CA, Boogaard M, et al: The MN1 oncoprotein activates transcription of the IGFBP5 promoter through a CACCC-rich consensus sequence. J Mol Endocrinol 38:113-125, 2007
32. Mumford JA, Horvath S, Oldham MC, Langfelder P, Geschwind DH, Poldrack RA: Detecting network modules in fMRI time series: a weighted network analysis approach. Neuroimage 52:1465-1476, 2010
33. Obayashi T, Hayashi S, Shibaoka M, Saeki M, Ohta H, Kinoshita K: COXPRESdb: a database of coexpressed gene networks in mammals. Nucleic Acids Res 36 (Database issue):D77-D82, 2008
34. Ozaki S, Nishizaki T, Ito H, Sasaki K: Comparative genomic hybridization analysis of genetic alterations associated with malignant progression of meningioma. J Neurooncol 41:167-174, 1999
35. Perry A, Gutmann DH, Reifenberger G: Molecular pathogenesis of meningiomas. J Neurooncol 70:183-202, 2004
36. Pfisterer WK, Coons SW, Aboul-Enein F, Hendricks WP, Scheck AC, Preul MC: Implicating chromosomal aberrations with meningioma growth and recurrence: results from FISH and MIB-I analysis of grades I and II meningioma tissue. J Neurooncol 87:43-50, 2008
37. Plun-Favreau H, Perret D, Diveu C, Froger J, Chevalier S, Lelièvre E, et al: Leukemia inhibitory factor (LIF), cardiotrophin-1, and oncostatin M share structural binding determinants in the immunoglobulin-like domain of LIF receptor. J Biol Chem 278:27169-27179, 2003
38. Presson AP, Yoon NK, Bagryanova L, Mah V, Alavi M, Maresh EL, et al: Protein expression based multimarker analysis of breast cancer samples. BMC Cancer 11:230, 2011
39. Ragel BT, Jensen RL: Aberrant signaling pathways in meningiomas. J Neurooncol 99:315-324, 2010
40. Ragel BT, Jensen RL: Molecular genetics of meningiomas. Neurosurg Focus 19(5):E9, 2005
41. Ransom CB, Liu X, Sontheimer H: BK channels in human glioma cells have enhanced calcium sensitivity. Glia 38:281-291, 2002
42. Ravasz E, Somera AL, Mongru DA, Oltvai ZN, Barabási AL: Hierarchical organization of modularity in metabolic networks. Science 297:1551-1555, 2002
43. Riemenschneider MJ, Perry A, Reifenberger G: Histological classification and molecular genetics of meningiomas. Lancet Neurol 5:1045-1054, 2006
44. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al: Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13:2498-2504, 2003
45. Sharan R, Ideker T: Modeling cellular machinery through biological network comparison. Nat Biotechnol 24:427-433, 2006
46. Shimon I, Yan X, Magoffin DA, Friedman TC, Melmed S: Intact leptin receptor is selectively expressed in human fetal pituitary and pituitary adenomas and signals human fetal pituitary growth hormone secretion. J Clin Endocrinol Metab 83:4059-4064, 1998
47. Smyth GK: Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3:Article3, 2004
48. Vidal M, Cusick ME, Barabási AL: Interactome networks and human disease. Cell 144:986-998, 2011
49. Wang H, Wang H, Zhang W, Fuller GN: Overexpression of IGFBP5, but not IGFBP3, correlates with the histologic grade of human diffuse glioma: a tissue microarray and immunohistochemical study. Technol Cancer Res Treat 5:195-199, 2006
50. Wang K, Li M, Hadley D, Liu R, Glessner J, Grant SF, et al: PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in wholegenome SNP genotyping data. Genome Res 17:1665-1674, 2007
51. Wilson CB: Meningiomas: genetics, malignancy, and the role of radiation in induction and treatment. The Richard C. Schneider Lecture. J Neurosurg 81:666-675, 1994
52. Wöhrle FU, Daly RJ, Brummer T: Function, regulation and pathological roles of the Gab/DOS docking proteins. Cell Commun Signal 7:22, 2009
53. Wrobel G, Roerig P, Kokocinski F, Neben K, Hahn M, Reifenberger G, et al: Microarray-based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progression. Int J Cancer 114:249-256, 2005
54. Wu J, Lingrel JB: KLF2 inhibits Jurkat T leukemia cell growth via upregulation of cyclin-dependent kinase inhibitor p21WAF1/CIP1. Oncogene 23:8088-8096, 2004
55. Xiang Y, Zhang CQ, Huang K: Predicting glioblastoma prognosis networks using weighted gene co-expression network analysis on TCGA data. BMC Bioinformatics 13 Suppl 2: S12, 2012
56. Yau C, Mouradov D, Jorissen RN, Colella S, Mirza G, Steers G, et al: A statistical approach for detecting genomic aberrations in heterogeneous tumor samples from single nucleotide polymorphism genotyping data. Genome Biol 11:R92, 2010
57. Zhang B, Horvath S: A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol 4:Article17, 2005
58. Zhu XL, Ai ZH, Wang J, Xu YL, Teng YC: Weighted gene co-expression network analysis in identification of endometrial cancer prognosis markers. Asian Pac J Cancer Prev 13: 4607-4611, 2012